Programs, populations, and payments verified via SAMHSA.
- Level of care
- Detox · Inpatient · PHP · IOP · MAT · Telehealth
- Service settings
- Outpatient, Residential/24-hour residential, Outpatient day treatment or partial hospitalization, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment, Residential detoxification, Long-term residential, Short-term residential
- Therapy approaches
- Brief intervention, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Trauma-related counseling, Telemedicine/telehealth therapy
- Age groups
- Children/Adolescents
- Special populations
- Clients with co-occurring mental and substance use disorders
- Medications used
- Acamprosate (Campral®), Disulfiram, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Clonidine, Medication for mental disorders, Nicotine replacement + 1 more
- Recovery supports
- Self-help groups, Housing services, Assistance with obtaining social services
- Facility operation
- Private non-profit organization